Evommune, Inc.
EVMN
$18.87
-$0.02-0.11%
NYSE
| 09/30/2025 | 06/30/2025 | 09/30/2024 | |||
|---|---|---|---|---|---|
| Net Income | 8.04% | 6.81% | 41.87% | ||
| Total Depreciation and Amortization | -17.07% | -0.53% | 1.85% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 100.56% | -3,684.02% | 224.19% | ||
| Change in Net Operating Assets | 158.04% | 57.11% | -157.96% | ||
| Cash from Operations | 63.24% | -9.66% | -204.05% | ||
| Capital Expenditure | -- | -- | 100.00% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -232.08% | 33.33% | -6.30% | ||
| Cash from Investing | -232.81% | 33.33% | -6.13% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | 12.26% | -0.65% | -5.56% | ||
| Issuance of Common Stock | -100.00% | 100.00% | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -100.00% | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 81.25% | -- | -- | ||
| Cash from Financing | -100.43% | 42,429.61% | -5.56% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -160.24% | 632.02% | -1,409.28% | ||